TERRAPIN STRATEGY, INC

Lobbying for SANA HEALTH · audiovisual technology

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Colorado · House · Senate · $10,000.00 income · posted Aug 7, 2026

Lobbying activity 3

Budget/Appropriations

General Introductions, appropriations

Medical/Disease Research/Clinical Labs

General Introduction; S 4251 The Veterans Novel Therapeutics Act

Veterans

S 4220 The Novel Therapeutics Act and education on PTSD therapies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.